| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. | Chief Business Officer | Common Stock | 18,986 | $570,472 | $30.05 | 02 Mar 2023 | Direct |
| Kymera Therapeutics, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 63,338 | 01 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | 01 Mar 2023 | 4 | -$22,132 | 4 | Chief Business Officer | 03 Mar 2023, 15:31 |
| KYMR | Kymera Therapeutics, Inc. | 01 Mar 2022 | 2 | $0 | 4 | Chief Business Officer | 03 Mar 2022, 15:30 |
| KYMR | Kymera Therapeutics, Inc. | 21 Jun 2021 | 1 | $0 | 4 | Chief Business Officer | 21 Jun 2021, 17:36 |
| KYMR | Kymera Therapeutics, Inc. | 21 Jun 2021 | 0 | $0 | 3 | Chief Business Officer | 21 Jun 2021, 17:32 |